Home https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ Health https://server7.kproxy.com/servlet/redirect.srv/sruj/smyrwpoii/p2/ If you beat COVID-19, but then develop this symptom weeks later, it can be fatal – BGR

If you beat COVID-19, but then develop this symptom weeks later, it can be fatal – BGR

  • A symptom that may seem benign may indicate that a person who has already beaten COVID-19 is developing a terrible, potentially deadly complication of the coronavirus.
  • Adults are also at risk of developing the same multisystem inflammatory syndrome seen in children who survived COVID-19.
  • People who develop a skin rash a few weeks after clearing COVID-19 infection may need immediate medical attention for a condition called MIS-A.

Coronavirus statistics include a misleading figure that would mislead many people into thinking that COVID-19 is not as dangerous as humans say. Of the nearly 40 million reported cases, about 1

.12 million have died from the disease. This means that everyone else has either recovered (29.23 million people) or is currently battling the disease (9.36 million). Many of these active cases will also recover in the coming weeks. What these numbers don’t tell you is that many people who clear the virus will have unexpected and potentially serious complications. The phenomenon has come to be called “Long COVID”, a chronic version of the disease in which patients continue to show various symptoms even after the virus has been beaten. In addition, some people are at risk of developing a potentially life-threatening syndrome that was first seen in children who survived COVID-19. And it can all start with a symptom that you may not consider very serious.

Multisystem Inflammatory Syndrome in Children (MIS-C) has now also been shown to affect adults, and the syndrome is called MIS-A. Both can be frightening and both can lead to life-threatening complications that require hospitalization and even intensive care. These conditions can occur without warning after clearing the coronavirus infection, but sometimes there are signs that the patient will experience MIS-C or MIS-A.

One of the first symptoms that COVID-19 survivors may see is a skin rash, NBC News reports. COVID-19 sometimes has unusual dermatological symptoms of its own, including rashes and a phenomenon called Covid Toe. But this new rash will appear after the disappearance of COVID-19.

“Before I even saw the patient,” said Dr. Alice Femia NBC News, “I said, ‘This has not been announced yet. This must be MIS-A. “The director of inpatient dermatology at NYU Langone Health in New York looked at the patient’s chart, which included several photos. A 45-year-old man had cared for his wife in previous weeks while she was suffering from COVID-19. The man had “dark red round spots on the palms of his hands and the soles of his feet.” NBC. He also had pink eyes and “extremely cracked” lips.

“The skin is right in front of your eyes,” Femia said. “You can’t help but see him.”

Dermatologists may be more likely to observe this symptom in patients, but not all of them will associate it with MIS-C or MIS-A. However, these skin rashes seem to be an early indicator of this terrible syndrome after COVID, which some people experience. The condition can be underdiagnosed in adults because many doctors do not even know how to look for it.

In addition to rashes, these patients may experience symptoms that may occur with COVID-19, as well as other conditions, including fever, chest pain, heart problems, and gastrointestinal problems. Importantly, patients with MIS-A would not show a key symptom of severe COVID-19, which is shortness of breath. Their PCR tests for COVID-19 will give negative results, while their antibody tests may be positive, suggesting a recent recovery from infection.

Doctors still cannot fully explain what causes inflammation in the body after the new coronavirus is cleared, but MIS-C and MIS-A can be fatal. There is currently no guaranteed treatment for these inflammatory syndromes in COVID-19 survivors.

NBC reported that children are usually treated with intravenous immunoglobulin, an antibody treatment that has nothing to do with COVID-19 antibodies that would provide plasma transfers. Adults often receive steroids and interleukin-6 inhibitors because they have already developed antibodies against COVID-19. Some doctors who have talked to NBC theorize that coronavirus antibodies can cause MIS-A. But for now, this is speculation, as there is no conclusive evidence to support it.

Chris Smith began writing about gadgets as a hobby, and before he realized it, he shared his views on technology with readers around the world. Whenever he doesn’t write about gadgets, he terribly fails to stay away from them, even though he tries desperately. But this is not necessarily a bad thing.

Source link